NeuroSafe外科手术几乎使前列腺癌手术后男性的勃起功能保留率翻了一倍。 NeuroSafe surgery nearly doubles erectile function retention in men post-prostate cancer surgery.

一种新的前列腺癌外科手术技术NeuroSafe,与标准方法相比,保留立体功能后外科手术的男子比例几乎增加了一倍。 A new prostate cancer surgery technique, NeuroSafe, nearly doubles the proportion of men retaining erectile function post-surgery compared to standard methods. 如果未发现任何癌症细胞,这种技术可以实时保存神经,从而改善病人的生活质量。 This technique allows for real-time nerve preservation if no cancer cells are detected, improving patients' quality of life. 在对344名男子进行的一项研究中,39%接受NeuroSafe的人一年后没有或轻度勃起功能障碍,而在标准外科组中这一比例为23%。 In a study of 344 men, 39% of those who received NeuroSafe had no or mild erectile dysfunction one year later, compared to 23% in the standard surgery group. 研究人员希望,这一方法将在国民保健制度上更广泛地提供。 Researchers hope this method will be more widely available on the NHS.